Contact this trialFirst, we need to learn more about you.
PD-L1 Inhibitor
Immunotherapy + Radiotherapy for Lung Cancer
Recruiting2 awardsPhase 2
Kelowna, British Columbia
This trial is testing a new immunotherapy drug to see if it's effective and safe to use with standard radiation treatment for early stage non-small cell lung cancer. If successful, this could become a new standard of care.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.